Indeed, USP family genes have been proposed as biomarkers in different malignancies [21, 42–45], and further research will have to show if USP5 may be suitable as a novel diagnostic marker and/or novel therapeutic target in pancreatic cancer. Here, USP5 is linked to familial pancreatic carcinoma.